The US Food and Drug Administration has refused to accept an application from Moderna to review its first mRNA seasonal flu ...
Refusal to review the submission is inconsistent with feedback at pre-Phase 3 and pre-submission consultations; Moderna ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results